T1	Participants 13 79	rheumatoid arthritis patients treated with etanercept monotherapy:
T2	Participants 343 402	etanercept-treated patients with rheumatoid arthritis (RA).
T3	Participants 411 630	Data from an RCT (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes [TEMPO]; n=682) and an observational registry (Rheumatoid Arthritis DMARD Intervention and Utilization Study [RADIUS II]; n=4341)
T4	Participants 730 796	patients initiating etanercept (monotherapy or with methotrexate).
T5	Participants 962 1039	RESULTS Patients from TEMPO and RADIUS II who received etanercept monotherapy
T6	Participants 1398 1443	more patients with lower baseline CDAI scores
